Latest

    Latest News

    First implant of MonarQ tricuspid valve replacement system performed in Copenhagen

    Nyra Medical secures investment for transcatheter mitral valve repair technology

    First-in-human procedure performed using Impella RP Flex

    Ninety-day readmission and mortality found to be higher among Black patients following PCI

    Late-breaking Xlimit randomised trial data shared at CSC 2022 congress

    Carmat resumes commercial implants of Aeson artificial heart

    CroíValve reports successful first in human implants of its Duo tricuspid coaptation valve system

    Rates of all-cause death align between invasive and conservative strategies in ISCHEMIA-EXTEND

    viz series d

    AI system to aid decision making for aortic aneurysm treatment

    BRIGHT-4 trial: Bivalirudin cuts 30-day mortality for STEMI patients undergoing PCI compared to heparin

    Soundbite Medical enters into a license agreement with VFLO Medical to bring its products to Chinese region

    CVRx launches new version of neuromodulation device intended to treat heart failure

    Siemens Healthineers to demonstrate remote capabilities of Corindus CorPath GRX robotic system using Mentice VIST simulator

    Use of clinical support platform “reduces risk of kidney injury” from PCI

    RELIEF clinical study to assess use of Cardioform septal occluder for migraine relief

    Neovasc Reducer assigned outpatient reimbursement code from CMS

    ReCor Medical announces consistent reduction of blood pressure in pooled analysis of three clinical trials at AHA 2022

    Siemens Healthineers to demonstrate remote capabilities of Corindus CorPath GRX robotic system using Mentice VIST simulator

    AHA 2022: SPYRAL HTN-ON MED study demonstrates “meaningful clinical benefits” consistent with other renal denervation trials

    AHA 2022: First data from BEST-CLI bring surgical bypass into the forefront of discussion for patients with high-quality great saphenous vein

    New surgical thresholds and need for multidisciplinary teams reflected in revised aortic guidelines

    Johnson & Johnson reaches agreement to acquire Abiomed

    Impella RP Flex with SmartAssist receives US FDA approval to treat right heart failure

    Transit Scientific announces US FDA clearance for XO RX angioplasty platform

    CX Aortic Vienna witnesses techniques “at the edge of endovascular intervention”

    CX Aortic Vienna provides timely reminder that rushing the patient to the operating room is “not always the answer”

    Carmat gains approval to resume clinical study of total artificial heart

    US FDA accepts post-approval study reports for Impella

    First patients treated in SAFE-TAVI clinical study

    Bruce Ovbiagele named editor-in-chief of the Journal of the American Heart Association

    Selution SLR receives US FDA investigational device exemption approval for coronary clinical trial

    Ticagrelor after CABG associated with a decreased risk of vein graft failure compared to aspirin

    LeAAPS trial to explore benefit of left atrial appendage occlusion in cardiac surgery patients at risk for stroke

    AccurKardia and Mawi link up to add automated ECG analytics for the new Mawi Watch

    HeartFlow receives US FDA approval for Plaque and RoadMap analysis AI products

    MedAlliance to be acquired by Cordis

    Rates of stroke and embolism lower with apixaban compared to rivaroxaban

    Abiomed gains FDA approval for Impella low profile sheath

    Swedish registry data point to survival benefit for younger patients undergoing CABG

    Analysis shows survival benefit in high-risk PCI supported by Impella

    Swedish and Dutch organisations agree to research collaboration

    CathWorks gains Japanese regulatory approval for FFRangio system

    EACTS 2022: Global studies will fill gap for “high-quality evidence” on invasive treatment of ischaemic cardiomyopathy

    Mortality drops for acute type A aortic dissection, still high for patients not receiving surgery

    EACTS 2022: “Wake up call” for trialists over gender balance

    flash

    FLASH results demonstrate “excellent safety profile” of the FlowTriever system in full US cohort

    Long-term P2Y12 monotherapy after PCI “may be a promising strategy”

    Enrolment completed in trial comparing PCI in diabetic patients

    Puzzle Medical wins 2022 TCT Shark Tank innovation competition

    Rivaroxaban may be an option for reducing radial artery occlusion in transradial coronary procedures

    Unloading with Impella for 30 minutes prior to PCI linked to reduced infarct size in STEMI patients

    First US TAVI procedure performed using SavvyWire guidewire

    Data from BIOSOLVE-IV and BIOMAG-I trials shared at TCT 2022

    FDA approves Onyx Frontier and Resolute Onyx stents for bifurcation PCI

    Clinical trial of TAVI in severe aortic regurgitation completes enrolment

    TCT 2022: TEER in cardiogenic shock patients shows promise for lowering mortality and heart failure hospitalisation

    TCT 2022: UNIVERSAL trial finds ultrasound did not reduce vascular complications during femoral access for cardiac procedures

    Medtronic expands US rollout of Evolut FX TAVI system

    Shockwave initiates all female coronary IVL registry study

    Breakthrough device designation granted for SirPlux Duo coronary DCB in small vessels

    TCT 2022: Amulet occluder keeps pace with Watchman at three years

    TCT 2022 hears “important data” from renal denervation trials

    TCT 2022: Valentin Fuster receives career achievement award

    TCT 2022: Pascal non-inferior to MitraClip in head-to-head trial in degenerative MR patients

    TCT 2022: No difference in rates of post-TAVI stroke seen with cerebral embolic protection device in PROTECTED TAVR

    US FDA grants 510(k) clearance for SavvyWire TAVI guidewire

    Precision medicine and upstream interventions in focus at TCT 2022 curtain raiser

    Abiomed given green light for RECOVER IV randomised trial

    Edwards’ Pascal Precision transcatheter valve repair system receives FDA approval for degenerative mitral regurgitation

    Key learnings from Manta device study to be presented at TCT

    Cardiac Implants announces successful adjustment procedure using its Tri-Ring device to treat TR

    Enrolment completed in TRANSFORM 1 trial of MagicTouch DCB

    TAVI costs comparable to surgery in low-risk patients, Canadian researchers conclude

    Vascade vascular and venous closure devices gain CE mark

    Latest Sapien TAVI valve features anti-calcification technology

    Three-year data “reinforce safety and efficacy” of Abbott’s Amplatzer Piccolo in infants with PDA

    The time for change is now: Call for action over “ageing and unbalanced” cardiothoracic surgery community

    Results of cuffless blood pressure monitor presented at AHA Hypertension Sessions

    First patient joins study of SSO2 therapy post-PCI

    Abbott’s Amplatzer Talisman PFO occlusion system launched in Europe

    AtriAN initiates second trial of pulsed field ablation in cardiothoracic surgery patients with paroxysmal AF

    Cardiovascular News’ top 10 most popular stories of August 2022

    FDA clears Viz.ai’s right-to-left ventricle ratio algorithm

    Latest centre begins using Philips’ Verisight Pro 3D intracardiac echocardiography catheter

    New DAPT labelling approved for Watchman FLX device

    First patient enrolled in Hyper II study evaluating hybrid approach in long diffuse CAD

    JenaValve raises US$100 Million to advance Trilogy TAVI system

    ESC 2022: Risk score predicts mortality for AF patients after TAVI

    ESC 2022: Survival benefit seen following use of Abbott’s HeartMate 3 LVAD

    ESC 2022: Transradial access is “gold standard” approach for percutaneous coronary procedures

    ESC 2022: MASTER DAPT continues to show merit for shortened dual antiplatelet therapy out to 15 months post-PCI

    ESC 2022: Kidney disease patients with coronary disease see no improvement in survival at five years with an invasive approach

    ESC 2022: FRAME-AMI sheds light on best strategy for selecting non-infarct lesions for PCI

    ESC 2022: High-risk aortic stenosis could be picked up using AI

    ESC 2022: POST-PCI trial finds no benefit to routine functional testing in high-risk PCI patients

    ESC 2022: AI outshines sonographer echocardiogram assessment in EchoNet-RCT

    ESC 2022: REVIVED data show PCI does not benefit patients with severe left ventricular dysfunction

    ESC 2022: SECURE trial finds “polypill” results in lower risk of cardiovascular events compared to usual care

    ŌNŌCOR reports first-in-human use of ŌNŌ system for removal of atrial blood clot

    ESC 2022: Timing of antihypertensive medication “makes no difference” to cardiovascular outcomes

    Programme released for TCT MedTech Innovation Forum

    Medtronic launches Onyx Frontier coronary stent following CE mark approval

    Miracor’s PiCSO technology approved by FDA for investigational device exemption study

    First-in-human procedure completed using ShortCut Mitral device

    Edwards gains CE mark for Pascal Precision system for mitral and tricuspid regurgitation

    Restore EF study “shows heart function, symptom improvements” for high-risk PCI patients supported by Impella

    AHA and CRF announce collaborative education programme

    Cardiovascular News’ top 10 most popular stories of July 2022

    “Worrisome” rise in cardiovascular disease predicted out to 2060

    “Positive” 30-day outcomes for patients receiving Optimum transcatheter aortic valve

    Cardiac surgeons among signatories to group seeking “critical appraisal” of evidence in cardiovascular medicine

    Genetic “cure” for cardiomyopathy is selected as winner of Big Beat Challenge

    Three-year results of RANGO registry presented at EuroPCR

    Neovasc gains approval for protocol supplement to COSIRA-II trial

    Digital drainage system for cardiac surgery “safe and effective”

    Pi-Cardia gains FDA nod for study of ShortCut leaflet splitting device

    Ultrasound renal denervation meets primary efficacy endpoint in RADIANCE II study

    Steps needed to include disadvantaged patients in mitral and tricuspid trials

    Cathbot completes enrolment in clinical study of robotic-assisted PCI in China

    Investigational device offers hope of a ‘shortcut’ to prevent coronary obstruction after TAVI

    New funding for research to examine use of blood pressure cuffs for heart failure patients with pacemakers

    FDA grants breakthrough status for Accucinch ventricular restoration system

    First patients enrolled in study of Booster spiral balloon therapy for acute myocardial infarction

    VenusP-Valve gains approval from China’s NMPA

    Medtronic announces co-promotion agreement with CathWorks, with path toward acquisition

    Stress testing can guide patient selection for coronary revascularisation

    Echocardiographers face “under-recognised” radiation exposure risk in the cath lab

    TCT MedTech Innovation Forum to spotlight opportunities for innovation

    Analysis shows “positive trend” with thinner strut stents in patients with small vessels

    HeartBeam expands software platform to cover unstable angina

    Cardiovascular News’ top 10 most popular news stories of June 2022

    Advanced NanoTherapies closes Series A funding round

    EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients

    First patients enrolled in Manta Ultra vascular closure device study

    AF after surgery is linked to an increased risk of heart failure hospitalisation

    Acutus launches expanded suite of left-heart access products

    CABG “associated with favourable outcomes and increased long-term survival” among octogenarians

    SonieVie

    SoniVie receives FDA IDE approval for pilot study to treat hypertension with renal artery denervation TIVUS technology

    CONFORM pivotal trial of CLAAS system begins enrolment

    NICE recommends new treatment to reduce stroke and heart attack deaths

    TVT 2022: DAPT after Watchman FLX LAAO is comparable to currently approved regimens

    TVT 2022: Late-breaking data point to favourable haemodynamic performance of latest-generation TAVI device

    TVT 2022: EXPAND registry shows benefit of MitraClip in patients outside of COAPT trial criteria

    TVT 2022: New data “debunk idea that patients with pacemakers may not be eligible for TEER”

    First patient treated in HEAL-IST clinical trial

    Patients with mitral annulus calcification at higher risk of mitral valve dysfunction

    First-in-human results of Captis embolic protection device presented at EuroPCR 2022

    Meta-analysis reveals “global collateral damage” of pandemic on cardiovascular care

    UK-wide randomised trial reports non-inferiority of TAVI to SAVR for all-cause mortality at one year

    EuroPCR 2022: DISCO RADIAL finds comparable radial artery occlusion rate between two access strategies

    AATS 2022: Concurrent tricuspid valve surgery and LVAD implantation do not lower the incidence of right heart failure

    SCAI 2022: Analysis looks at coronary IVL outcomes in women and men

    SCAI names Sunil Rao as incoming president

    Cordella meets safety and efficacy endpoints in SIRONA 2 clinical trial

    Shockwave Medical and Genesis MedTech obtain regulatory approval in China for intravascular lithotripsy

    Adept announces Prone Support product launch

    EuroPCR 2022: Sustained reduction in TR seen at one-year in CLASP TR study

    EuroPCR 2022: Single-digit pacemaker rates seen in TAVI with cusp overlap technique

    EuroPCR 2022: First-in-human results of SavvyWire TAVI guidewire support safety

    EuroPCR 2022: Impact of COVID-19 lockdown on STEMI care revealed

    SCAI 2022: PCI for STEMI “yet to reach pre-pandemic levels”

    Biotronik shares new safety data for Magmaris scaffold system at EuroPCR 2022

    EuroPCR 2022 hears new data on robotic PCI

    Vivasure Medical announces Series D financing to advance portfolio of PerQseal vessel closure devices

    EuroPCR 2022: Short DAPT shows benefit for high-bleeding risk patients regardless of PCI complexity

    EuroPCR 2022: Studies underscore potential of renal denervation as an adjunctive therapy for hypertension

    Medtronic gains FDA approval for Onyx Frontier drug-eluting stent

    Analysis charts “significant” growth of US TEER procedures since 2012

    Abbott funds programme to boost diversity in clinical trial leadership

    Cardiovascular News’ top 10 most popular stories of April 2022

    Artificial intelligence could make endovascular aortic repair outcomes more predictable

    Health Canada approval granted for SavvyWire TAVI guidewire

    Japanese and US regulatory approvals granted for BioFreedom stent

    First patient enrolled in EXPAND TAVR II trial

    Medtronic names Laura Mauri as new chief scientific, medical and regulatory officer

    SCAI issues position paper on transaxillary arterial access

    Translumina announces launch of dual drug polymer-free coated stent

    Corindus relocates Massachusetts headquarters to accommodate company growth

    FDA approves coronary use of XO Cross support catheter system

    Quest International and CathWorks partner to scale up FFRangio

    viz series d

    Viz.ai raises US$100 million in Series D funding to expand AI technologies

    VenusP-Valve gains CE mark

    CeloNova to seek medical device partnerships

    ACC.22: TAVI patients treated with edoxaban see fewer incidences of leaflet thrombosis compared to DAPT

    Cardiovascular News’ top 10 most popular stories of March 2022

    FEops Heartguide receives FDA clearance for LAAO planning capabilities

    First patient in Japan treated with Impella 5.5 with SmartAssist

    First patient enrolled in BIOMICS study for CTO-PCI

    ACC.22: Analysis finds lower rate of structural valve deterioration with TAVI than SAVR at five years

    ACC.22: NACMI registry finds reducing rates of death among STEMI patients with COVID-19

    ACC.22: FFR-guided PCI non-inferior to IVUS for intermediate coronary stenosis

    ACC.22: Three-year data show “durable blood pressure reductions” through renal denervation

    ACC.22: “Promising” one-year results for Pascal device in CLASP-TR trial

    Corvia announces publication of REDUCE LAP-HF II data

    ACC.22: FAME 3 shows FFR-guided PCI leads to a faster recovery versus surgery

    SafeCross transseptal balloon gets first commercial use

    Philips launches Ultrasound Workspace at ACC.22

    SCAI aims to minimise risks in medical proctoring of new techniques and technologies

    FDA approval granted for Mitris Resilia mitral valve replacement

    Shockwave coronary IVL gains Japanese approval

    First patient enrolled in PICSO-AMI-V study

    RADIANCE-II renal denervation trial completes enrolment

    Carmat sets date for resumption of implants of artificial heart system

    Deep learning tool could predict future myocardial infarction

    First-in-human study paves way for further clinical trials of Valvosoft

    Expert group sets out principles for device-led hypertension trials

    Medical Ingenuities conducts first commercial cases with transformational radial haemostasis band system

    Venus Medtech targets European growth with senior appointment

    Woman patient

    Women less likely to receive cardiogenic shock treatment

    Dyspnoea and fatigue “warning signs of greater risk” for NSTEMI patients

    Xeltis announces “promising outcomes” in restorative graft trials following EU financing

    ACC issues clinical guidance on cardiovascular consequences of COVID-19

    CSI’s Propel pVAD system gets first-in-human use

    First patient treated in study of PerQseal+ vessel closure device

    Remote blood pressure monitoring beneficial for stroke survivors in under-resourced areas

    Ryan Egeland joins Big Sky Biomedical

    Medtronic expands reach of AI-powered surgical video management and analytics platform

    Cardiovascular News’ top 10 most popular stories of February 2022

    CRT 2022: “Reassuring” two-year outcomes for bicuspid TAVI

    CRT 2022: Novel transfemoral mitral valve repair technology wins innovation competition

    CRT 2022: COBRA-REDUCE findings do not support routine use of nanocoated stent with short-duration DAPT

    CRT 2022: Four-year LRT data “support TAVI in low-risk patients”

    VISION study concludes troponin is a benchmark for cardiac surgery risk

    Enrolment in BIOMAG-I trial of resorbable magnesium scaffold completed

    CRT 2022: SURPASS registry shows low rate of adverse events associated with Watchman FLX

    Women underrepresented in cardiovascular clinical trial leadership positions

    Tria

    CRT 2022 hears results of animal study of Tria TAVI valve

    CRT 2022: Final BIOFLOW-V results “affirm durability” of Orsiro out to five years

    Partnership to promote wearable tech in cardiology trials

    High coronary artery calcium score increases risk of heart attack or stroke

    Teleflex catheters and coronary guidewires cleared for CTO PCI

    Valve-in-valve TAVI outperforms repeat SAVR for in-hospital mortality

    Siemens introduces “integrated” cath lab imaging system, Artis icono biplane

    Ross procedure “associated with better long-term outcomes” for aortic valve replacement

    Abbott’s CardioMEMS HF system receives FDA approval for use in earlier-stage heart failure

    On-pump and off-pump CABG confer similar outcomes over 10 years

    Heart team approach points to mortality benefit in complex cardiac patients

    New technique outperforms manual assessment of thoracic aortic aneurysm growth

    Robert Califf to return as US FDA commissioner

    3D printing to support physician training and coronary device testing

    Enrolment completed in BIOADAPTOR trial of Dynamx coronary implant

    Boston Scientific closes acquisition of Baylis Medical Company

    MedHub announces investment and pivotal study completion

    Supreme drug-eluting stent “safe and effective” in complex coronary lesions

    HeartFlow and Longview terminate merger agreement

    Lung cancer patients with higher level of coronary calcium at increased risk for adverse cardiovascular events

    IVUS “improves long-term cardiac survival” after long drug-eluting stent implantation

    Cardiovascular News’ top 10 most popular stories of January 2022

    Acarix submits breakthrough designation request to FDA for heart failure diagnosis tool

    “Game changing” photon-counting CT system arrives at John Radcliffe Hospital

    Philips expands haemodynamic assessment in its Lumify handheld ultrasound system

    Second phase of ASCENT ASD trial begins

    Corvia atrial shunt fails to reduce heart failure events in REDUCE LAP-HF II trial

    First patient enrolled in RISE SC study of coronary balloon

    Breakthrough designation granted to CardiaAMP cell therapy system for heart failure treatment

    CroíValve completes funding round for study of Duo system

    Death due to cardiovascular disease more likely among Black adults born in the USA

    SCAI publishes expert consensus statement on sex-specific considerations in myocardial revascularisation

    STS 2022: Large-scale analysis points toward positive outcomes in bicuspid aortic stenosis patients receiving surgery

    PROACT clinical trial results published for On-X mechanical mitral valve

    SCAI issues updated expert consensus statement on cardiogenic shock

    STS 2022: Closer ties between surgeons and cardiologists among goals for incoming president

    STS 2022: Socioeconomic status may impact outcomes after mitral valve surgery

    InnovHeart completes funding round to advance Saturn TMVR system

    JIM 2022 moves to June slot

    First patient enrolled in TRANSFORM II study of sirolimus-coated balloon

    “Considerable” reduction in PCI-related radiation reported in last decade

    Burden of aortic stenosis likely to challenge UK treatment capacity, researchers warn

    FDA issues two final guidances for including patient perspectives in medical device studies

    Grant funding for 3D-printed paediatric heart models

    Study suggests a more proximal landing zone is preferred for TEVAR of acute type B aortic dissections

    Guidelines recognise potential role for earlier endovascular treatment of uncomplicated type B aortic dissection

    New publication “extends evidence for clinical benefit” with CytoSorbents’ haemoadsorption technology into type A dissection aortic surgery

    Scoreflex NC PTCA catheter gains FDA premarket approval

    Gore’s Cardioform Septal Occluder reaches 10-year milestone

    Young surgeons to benefit from Transatlantic grant scheme

    Prolonged TV watching may increase risk of venous thromboembolism

    Philips integrates cloud-based AI and 3D mapping into its mobile C-arm system series

    IVL

    Cardiovascular Systems announces development of IVL technology for the treatment of coronary and peripheral arterial diseases

    TAVI associated with reduced odds of in-hospital mortality for bicuspid valve patients

    Pioneering pig to human heart transplant heralded as a breakthrough

    AATS and STS opt not to endorse joint coronary revascularisation guidelines

    Omicron surge sees STS move 2022 annual meeting online

    Terumo welcomes upgraded recommendation for radial access in revascularisation guidelines

    Robocath completes European study of robot-assisted PCI

    Impella gains a trio of regulatory approvals

    Evolut PRO TAVI valve gains approval in China

    Cardiovascular News’ top 10 most popular stories of December 2021

    First patient enrolled in COSIRA-II trial of Neovasc Reducer

    Endotronix announces FDA approval for PROACTIVE-HF pivotal trial design change

    Partnership to develop training system for complex valve-in-valve procedures

    Vesalio

    Vesalio initiates clinical study evaluating enVast thrombectomy system in patients with STEMI

    FDA clears CavaClear IVC filter removal laser sheath

    Tria

    First clinical results for Tria biopolymer valve published

    Sapien 3

    Sapien 3 with Alterra prestent gains FDA approval

    US physicians “among nation’s first” to implant neurostimulator technology for advanced heart failure

    Research suggests many patients may be safely discharged without opioids after cardiac surgery

    EMPAKT CHF trial points to change in assessment acute heart failure patients

    Initial implants of Thubrikar TAVI system to commence

    AI improves confidence in CAD detection from a stress echocardiogram

    HeartFlow submits premarket application for coronary plaque assessment

    Svelte Medical Systems receives US FDA approval for Slender IDS and Direct RX

    Opsens files 510(k) submission to US FDA for TAVI guidewire

    Joanna Chikwe appointed as editor-in-chief of The Annals of Thoracic Surgery

    Machine learning predicts 10-year risk of death in patients with suspected or known coronary artery disease 

    Heart team approach central to updated coronary revascularisation guidelines

    Machine learning may help identify people at risk of thoracic aortic aneurysm

    Coronary artery modelling technology enables 3D reconstruction of coronary vasculature

    Philips expands cardiac ultrasound portfolio

    Tria

    Foldax commences clinical study of Tria surgical aortic valve in India

    Venus Medtech announces Cardiovalve acquisition

    SyMap Medical closes US$100 million financing round

    Restore Medical announces preliminary results from first-in-human use of ContraBand

    Survey: Bullying “commonly experienced” by UK cardiology trainees

    Interim REVERSE-IT trial results published in NEJM Evidence

    Cardiovascular News’ top 10 most popular stories of November 2021

    AI

    AI-based algorithm could predict outcomes after cardiac surgery

    Soundbite Medical gains fifth US patent for its plaque modification technology

    Robocath announces completion of first robotic coronary angioplasty with R-One in China

    CSI recalls Wirion embolic protection device

    PCR London Valves: Two-year GALILEO data show comparable outcomes for TAVI with self-expanding or balloon-expandable valves according to physician discretion

    PCR London Valves: First clinical data backs use of Jenavalve TAVI system in patients with aortic regurgitation

    PCR London Valves hears first results from NeoChord Nexus mitral repair device

    First 20 patients treated in first-in-man study of SavvyWire TAVI guidewire

    Research reveals improved outcomes and decreased mortality in management of aortic dissections with care plans designed by multidisciplinary expertise

    First patients enrolled in FAST III study of vFFR-guided PCI

    ESC publishes pandemic guidance on diagnosis and management of cardiovascular disease

    SCAI pushes revised standardised language to improve cardiogenic shock care

    Findings of meta-analysis “move the conversation forward” on left main revascularisation

    Nonagenarians should not be denied TAVI based solely upon age

    AHA 2021: Updated risk score aims to predict contrast-associated kidney injury after PCI

    AHA 2021: VEST device may lead to increased saphenous vein graft longevity after CABG

    HeartVista receives FDA clearance for use of its AI software on Siemens MRI scanners

    AHA 2021: RAPID CABG trial finds in favour of bypass surgery sooner after ticagrelor cessation

    AHA 2021: Asymptomatic AS patients benefit from early valve replacement surgery

    “Promising” early data shared on alternatives to paclitaxel DCBs at TCT 2021

    Caption Health and Ultromics partner to increase availability of heart disease detection and management tools 

    Abbott research highlights opportunities for improvements in diagnosis and treatment of cardiovascular disease

    Ron Waksman joins SIS Medical AG advisory board

    Cardiovascular Systems announces enrolment in first-in-human study of everolimus-coated coronary DCB

    Patients more likely to survive a cardiac arrest in the operating room than the cath lab

    Two-year results of mitral valve repair using ChordArt device published

    Medtronic announces 2045 net zero emissions ambition to combat climate change

    TCT 2021: BIOSOLVE-IV data offer reassurance over rates of scaffold thrombosis from Magmaris bioresorbable scaffold

    TCT 2021: Six-month TRISCEND results “encouraging” for Evoque tricuspid valve

    TCT 2021: Early data presented for Intrepid TMVR using transfemoral delivery system

    TCT 2021: SWISS-APERO trial finds lower rate of peri-device leak in Amulet compared to Watchman FLX LAAC device

    TCT 2021: Endoscopy study could have implications for post-PCI antiplatelet regimens

    TCT 2021: Studies show improved outcomes for high-risk PCI patients using Impella

    TCT 2021: LAAC remains non-inferior to NOAC for cardiovascular events at long-term follow-up

    TCT 2021: Five-year SURTAVI data show comparable performance for TAVI and SAVR on mortality, stroke

    TCT 2021: CHOICE-CLOSURE finds higher rate of access-related vascular complications in plug-based closure strategy post-TAVI

    TCT 2021: TAVI in low-risk patients is cost effective, PARTNER 3 finds

    TCT 2021: CHEETAH study demonstrates safety of continuous aspiration to remove blood clots in the heart

    TCT 2021: “Sustained benefit” in patients undergoing IVL prior to coronary stenting

    TCT 2021: Patients with diabetes undergoing PCI have less target lesion failure with amphilimus-eluting stents

    TCT 2021: Randomised trials show “consistent” reduction in blood pressure through renal denervation

    TCT 2021: Six-month RADIANCE-HTN TRIO results “open a window” for renal denervation

    TCT 2021: QFR-guided lesion selection improves PCI outcomes in FAVOR III trial

    TCT 2021: CABG “remains the treatment of choice” for complex, three-vessel coronary artery disease

    TCT 2021: Medtronic unveils data on hypertension treatment preferences, launches SPYRAL AFFIRM study

    TCT 2021: Philips to showcase developments in its interventional portfolio

    Aktiia announces Series A funding round

    ReValve Solutions announces first use of its Palmetto mitral valve replacement system

    TCT 2021: Studies to highlight patient outcomes with Impella

    AHA and ACC release clinical guidelines for evaluation of chest pain

    EACTS speakers question evidence underpinning guidelines for left main revascularisation

    Longest available real-world follow-up data for Tendyne valve support use of device in select patients

    Enrolment completed in study of Teleflex QuikClot device

    Research finds poor level of surveillance following aortic dissection repair

    CRF waives cost for digital access to TCT 2021

    PIONEER III trial results demonstrate safety and efficacy of HT Supreme stent

    Cardiac CTA parameters predict post-TAVI mortality

    First European implants of Trilogy TAVI system completed

    Heartflow announces start of REVEALPLAQUE clinical trial

    Study charts “inequities” in growth of TAVI in US hospitals

    Ethnic and racial minority cardiologists face professional discrimination and exclusion

    EACTS 2021: Panel urges action over lack of representation of women in coronary revascularisation trials

    Clinical study of SavvyWire TAVI guidewire commences

    Next generation of aortic surgeons need open and endovascular skills

    ReCor Medical’s Paradise ultrasound renal denervation system used in first German cases

    Baylis Medical Company to sell its cardiology business to Boston Scientific

    New technologies will simplify and shorten aortic surgical procedures while reducing radiation

    Patients should get a choice between open and endovascular surgery for aortic conditions, CX audience agrees

    Open surgery remains a well-accepted as option to treat challenging aortic arch

    VIVA 2021: Consensus established for appropriate use of IVUS in peripheral interventions

    NeoChord announces completion of first-in-human case with NeXus TMVr technology

    Cardiovascular News’ top 10 most popular stories of September 2021

    Lankenau Heart Institute and Philips announced integrated cardiovascular solutions partnership

    FDA monitoring gender differences in outcomes with LAAO devices

    Tria

    Enrolment completed in study of Tria aortic valve

    Cardiovascular Systems

    First patient treated with Cardiovascular Systems’ ViperCross peripheral support catheter

    Siemens launches Luminos Impulse fluoroscopy system

    Abbott’s Amplatzer Talisman gains FDA approval

    Orsiro Mission DES

    Biotronik gains FDA approval for the Orsiro Mission drug-eluting stent

    Waiting list mortality for coronary procedures exacerbated during pandemic

    Open Stent Solution closes €2.5 funding round

    HRX digital health event moved to September 2022

    Neovasc to begin COSIRA-II trial of Reducer for refractory angina

    FDA approves Abbott’s Epic Plus tissue valves for mitral and aortic valve replacement

    Registry data show comparable outcomes for bicuspid and tricuspid TAVI in low-risk patients

    Surgical team completes first implant of Aeson bioprosthetic heart in a female patient

    Ultrasound guidance “should be routine” for transfemoral TAVI access

    Randomised trials needed to evaluate safety and efficacy of TMVR

    Abbott receives FDA approval for Portico with FlexNav TAVI system

    OpSens receives Health Canada approval to begin clinical study of TAVI guidewire

    Long-term preclinical results of Xeltis’ restorative CABG graft presented at ISACB 2021

    TCT 2021: Late-breaking trials programme announced

    ESH position paper highlights renal denervation as a third option for hypertension management

    Peijia Medical announces first implant in the clinical trial of its TaurusNXT TAVI system

    New imaging technique has the potential to identify patients at high risk of aortic degeneration

    CytoSorbents files IDE for clinical trial of DrugSorb-ATR used during cardiothoracic surgery

    STENTiT makes trio of appointment to its medical advisory board

    No-touch CABG technique “reduces risk of vein graft occlusion” after 12 months

    ABILITY Diabetes Global enrols thousandth patient

    Cannabis use in younger adults linked to increased risk of myocardial infarction

    Cardiovascular News’ top 10 most popular stories of August 2021

    HeartFlow announces enrolment of first three patients in FUSION trial

    ESC 2021: STOPDAPT-2 ACS does not support clopidogrel monotherapy one-month after ACS

    ESC 2021: Abbott’s Amulet occluder shows promise against Watchman device in AF treatment

    stroke risk factors

    ESOC 2021: Non-traditional risk factors for heart attack and stroke rising more steeply in women

    ESC 2021: Systematic pressure wire assessment has no additional benefit at diagnostic angiography

    MedAlliance announces first patient enrolment in SELUTION DeNovo study

    ESC 2021: TOMAHAWK trial does not support early coronary angiography in cardiac arrest without ST elevation

    ESC 2021: Edoxaban shown to be noninferior to warfarin for adverse events after TAVI

    ESC 2021: One-month dual antiplatelet therapy post-stent implant benefits high bleeding risk patients

    ESC 2021: Drones touted as the future of defibrillator delivery

    ESC 2021: New guidelines for the diagnosis and treatment of acute heart failure published

    ESC 2021: Study charts impact of following health advice after a heart attack

    Second hospital implants Aeson bioprosthetic artificial heart

    Medtronic gains FDA approval for its latest-generation TAVI system

    ESC 2021: Family history outweighed by lifestyle choices in study of premature heart attacks

    EMPOWER trial to study Carillon mitral contour system

    Urgent TAVI patients more likely to be readmitted than elective cases

    Ten-year outcomes of Yukon DES in diabetic patients published in JAHA

    Ultromics completes US$33 million Series B funding round

    FDA grants breakthrough device designation to Impella ECP

    AI

    Algorithm predicts heart failure hospitalisations

    Sinomed announces the first commercial implantation and European launch of the HT Supreme DES

    App launched to cut time to treatment for STEMI patients

    Second US FDA breakthrough device designation granted to CytoSorbents’ DrugSorb-ATR

    Abbott’s Amplatzer Amulet gains US FDA approval

    Occlutech gains IDE approval for OCCLUFLEX pivotal study

    “Virtual contrast agent” could offer benefit in cardiac MRI assessment

    Caption Health gains NTAP authorisation from CMS for AI-guided ultrasound platform

    Women underrepresented in cardiovascular clinical trials

    Realview Imaging gains FDA approval for Holoscope-i system

    Cardiovascular News’ top 10 most popular stories of July 2021

    Analysis reports “dramatic” drop in cardiac surgery procedures during COVID-19

    US launch for Abbott’s Ultreon AI-based coronary imaging platform

    Edwards’ Konect Resilia and Mitris Resilia gain Health Canada approval

    PCI procedures drop by 10% in USA since 2010, research suggests

    AngelMed launches its Guardian device in the USA

    TVT 2021: MitraClip reduces hospitalisation in patients with secondary MR and heart failure

    Medtronic launches Prevail DCB in Europe

    CathWorks FFRangio system receives reimbursement approval in Japan

    TVT 2021: Aborted TEER leads to poorer outcomes in mitral valve surgery

    TVT 2021: 3M study suggests minimalist TAVI is safe, leads to “substantial” cost savings

    TVT 2021: Outcomes in low-risk bicuspid and tricuspid TAVI patients similar at one year

    TVT 2021: Two-year PINNACLE FLX results report low rate of ischaemic stroke for Watchman FLX

    MedAlliance launches Origin balloons for vessel preparation

    Ancora Heart secures US$80 million in financing

    HeartFlow announces merger agreement

    First Aeson bioprosthetic artificial heart implanted in USA

    Pacemaker implantation after SAVR points to increased mortality and heart failure hospitalisation

    First patients treated with reSept ASD occluder in IDE trial

    FDA approval for SafeCross transseptal RF system

    Cardiovascular societies demand action to combat physician burnout

    Xeltis initiates synthetic restorative pulmonary heart valve pivotal trial

    Common cath lab practices under the microscope in AHA review

    Cardiovascular News’ top 10 most popular stories of June 2021

    CytoSorbents gains IDE for STAR-T trial to remove ticagrelor during cardiothoracic surgery

    virtual stroke care

    Carta Healthcare’s AI software certified for use in CathPCI Registry

    Sinomed partners with NUI Galway for HT Supreme stent trial

    More experienced TAVI centres “less likely to use heart team approach”

    First patient treated with VeriSight Pro 3D intracardiac echocardiography catheter

    Xience stent receives US FDA approval for short-duration DAPT

    Cardiothoracic surgery guidelines updated to optimise blood management among cardiac patients

    Electroducer raises funding to market its external pacemaker device

    Vaccine myocarditis risk “far outweighed” by COVID-19 infection

    Pandemic contributes to worsening heart attack outcomes, study finds

    AngelMed gains FDA approval for enhanced real-time cardiac monitor for ACS events

    One in eight CABG patients readmitted within 30 days, meta-analysis finds

    Medtronic Canada completes end-to-end remotely-guided TAVI procedure

    Tendyne receives breakthrough designation for MAC patients

    Philips iFR Coregistration SyncVision

    Royal Philips announces start of DEFINE GPS study

    virtual stroke care

    Stroke and heart condition patients want virtual healthcare to continue post pandemic, surveys indicate

    Registry DAPT data “could support clinical trials”

    Long-term study finds QoL improvements in CABG patients despite complications

    PCI complexity does not influence efficacy of ticagrelor or prasugrel in acute coronary syndrome patients

    “Rapid increase” in cardiovascular disease-related deaths in Asia

    Study of CorWave’s LVAD presented at ASAIO annual meeting

    Circulation publishes special edition dedicated to disparities in cardiovascular medicine

    Shockwave’s coronary IVL device gains TPT payment approval

    Delaying CABG after AMI may not improve outcomes

    Caution needed for TAVI in younger, low-risk aortic stenosis patients

    Neurescue’s aortic occlusion device gains US FDA approval

    Pulmonary artery proportional pulse pressure monitoring could improve survival for heart failure patients

    TRISCEND study demonstrates significant reduction in TR with Evoque tricuspid valve

    GE Healthcare and ACC partner to advance AI in cardiology

    Medtronic stops sale of its HVAD system

    Cardiovascular News’ top 10 most popular stories of May 2021

    Physician gender does not impact outcomes in PCI patients

    Siemens Healthineers receives CE mark for the ACUSON AcuNav Volume ICE catheter

    LivaNova completes initial divestiture of its heart valve business

    Female aortic dissection patients presenting later, have higher mortality

    Abiomed acquires breakthrough device company preCARDIA

    Sinomed announces presentation of PIONEER III data at EuroPCR 2021

    COVID-19 puts a spotlight on the need for investment in resources for cardiac surgery

    EuroPCR 2021: Interventional cardiologists sound the alarm over silent impact of the pandemic

    MDR comes into effect across EU

    Tria

    First-in-human use of Tria biopolymer heart valve completed

    complete-revascularisation

    First patients treated with Aortix pMCS device

    EuroPCR 2021: Image-guided PCI study demonstrates non-inferiority of ultra-thin stent

    TricValve transcatheter bicaval valve system receives CE mark

    EuroPCR 2021: Study details dual mechanism of Diamondback orbital atherectomy system

    EuroPCR 2021: FUTURE-II hints at promise for Firesorb bioresorbable scaffold

    EuroPCR 2021: Meta-analysis supports elective coronary revascularisation

    ACC.21: Clopidogrel monotherapy trumps aspirin for long-term maintenance after PCI

    EuroPCR 2021: 10-year DISCOVER-FLOW results back HeartFlow FFRct analysis

    ACC.21: VOYAGER PAD analysis shows reduced risk of ischaemic events in PAD patients receiving rivaroxaban

    EuroPCR 2021: Late-breaking data demonstrate long-term benefits of Medtronic radiofrequency renal denervation in real-world hypertensive patients

    EuroPCR 2021: Two-year results of Evolut Low Risk trial “reassuring” for TAVI in low-risk patients

    EuroPCR 2021: Biotronik touts two-year data from BIOSOLVE-IV registry

    EuroPCR 2021: Registry data show low rates of PVL and PPI for Acurate neo2

    EuroPCR 2021: Philips shares cardiac imaging and software developments

    ZOLL Medical receives FDA IDE approval for ISO Shock study

    Abbott’s Navitor TAVI system receives CE mark

    ACC.21: High-sensitivity troponin T-test protocol did not improve outcomes in suspected ACS patients

    ACC.21: Pandemic has seen burnout “double” among cardiology professionals

    ACC.21: FLOWER-MI finds no benefit to FFR-guided PCI in STEMI patients with multi-vessel disease

    ACC.21: DAPT de-escalation may benefit AMI patients

    ACC.21: Registry data show low rate of stroke at one year following LAAO with Watchman

    ACC.21: Apixaban not superior to standard of care following TAVI

    ACC.21: LAAO after heart surgery offers “new paradigm” for stroke prevention in AF patients

    COBRA PzF stent demonstrates long-term safety at five years post-PCI

    Philips adds haemodynamic measurement to Azurion image-guided platform

    Hostile environment: Cardiologists report high prevalence of discrimination and harassment in the workplace

    Study shows increasing diversity among US cardiothoracic surgery residents

    ACC.21: Digital app should replace stent cards as a patient PCI record

    Cardiology trainees require preparation to adapt to shift towards telemedicine

    AGENT IDE trial to evaluate DCB-use in patients with coronary in-stent restenosis

    Mild COVID-19 unlikely to lead to lasting heart damage

    Abbott initiates trial focusing on twin AF and heart failure treatments

    Cardiovascular News’ top 10 most popular stories of April 2021

    ACC.21: App speeds up time to PCI for STEMI patients

    SCAI names Timothy Henry as president

    Mitral regurgitation patients treated with TEER will require mitral replacement surgery if treatment fails

    Medtronic’s Evolut PRO+ TAVI system gains CE mark

    SCAI 2021: ISCHEMIA trial population not reflected in real-world patients

    SCAI 2021: Robotic PCI achieves high clinical and technical success “in a wide spectrum of lesions”

    SCAI 2021: Prolonged DAPT “should remain the standard of care” in ACS patients

    SCAI updates consensus guidelines on cath lab standards

    SCAI 2021: Research lays bare the impact of the COVID-19 pandemic on STEMI care

    SCAI 2021: Interim OPTIMIZE PRO results point to benefit for cusp overlap TAVI technique

    Hospitalised COVID-19 patients at risk of developing heart failure

    CE mark for BACE device for functional mitral regurgitation

    CytoSorbents granted US FDA approval for STAR-T trial

    Societies publish initial findings of NACMI registry of STEMI patients with COVID-19

    First patient enrolled in PROTECT IV randomised controlled trial of Impella

    Researchers create heart replicas from CT images

    UK study suggests that COVID-19 patients are at elevated risk during cardiothoracic surgery

    AcQCross transseptal crossing devices gain US FDA clearance

    First procedure performed in SMART head-to-head TAVI study

    Next generation TriClip gains CE mark approval

    Cardiovascular News’ top 10 most popular stories of March 2021

    COVID-19 “lays the foundation for a digital shift in cardiovascular care”

    Xience stent receives CE mark for short duration DAPT

    Dipti Itchhaporia begins term as ACC president

    Randomised trial data supports use of the PleuraFlow system

    One in three female cardiologists report unwanted advances

    Older STEMI patients found to be more reluctant to undergo PCI in Chinese study

    B Braun and Infraredx collaborate on IDE clinical trial for the SeQuent Please ReX

    Alvimedica gains CE mark approval for Fluydo NC balloon catheter

    Medtronic receives FDA approval for Harmony transcatheter pulmonary valve

    Academic reputation does not determine following for interventional cardiology influencers

    Cordella pulmonary artery pressure sensor reaches 100-implant milestone

    Viagra may prolong life for men with coronary artery disease

    Shockwave Medical to bring IVL to the Chinese market

    Mavacamten granted US FDA new drug application

    CRT 2021: Three-year COMPARE ABSORB results show similar TLF rate between Absorb scaffold and Xience stent

    CRT 2021: Polymer-free amphilimus-eluting stent non-inferior to zotarolimus-eluting stent in PCI patients

    Lab-grown heart valves capable of growth in recipient, research finds

    Imbio receives FDA 510(k) clearance for cardiothoracic imaging algorithm

    Cardiovascular Systems announces first uses of Wirion embolic protection system

    CytoSorbents files IDE for US trial on ticagrelor removal during cardiothoracic surgery

    Elixir Medical commences INFINITY-SWEDEHEART randomised study of DynamX bioadaptor

    CRT 2021: BIOSTEMI shows superiority of Orsiro stent to Xience for target lesion failure at two years

    CRT 2021: One-year outcomes after TAVI in low-risk bicuspid aortic stenosis patients meet expectations

    Five-year results of Gore REDUCE clinical study published

    ACC.21 late-breaking clinical trial programme announced

    CRT 2021: Registry data highlights growing use of DOACs among bioprosthetic heart valve patients

    CRT 2021: Registry data finds BASILICA has a low coronary artery obstruction rate

    Cardiovascular News’ top 10 most popular stories of February 2021

    Approval allows use of single access Impella procedure across Europe

    ControlRad Select imaging system gains FDA market clearance

    Three-month DAPT after PCI with Synergy stent supported in EVOLVE Short DAPT trial

    Societies collaborate to develop universal heart failure definition

    MedAlliance gains FDA breakthrough designation for sirolimus DEB treatment of de novo coronary lesions

    ICS announces first use of its Emblok system in Europe

    FDA approval for Viola clampless proximal anastomosis device

    Two-year PARTNER 3 outcomes show convergence between TAVI and surgery on stroke and death

    CRT 2021: Analysis compares cangrelor favourably to glycoprotein IIB

    Analysis shows proportionality fails to account for divergent COAPT and Mitra-FR trials

    Data support use of AI to accurately estimate lesion-specific ischemia

    Inovise gains breakthrough designation for non-invasive heart failure management system

    Occlutech announces completion of enrolment in study of atrial flow regulator in heart failure patients

    CRT 2021: DISRUPT CAD III sub-study shows efficacy of IVL in patients with longer lesions

    Terumo reaches agreement to acquire predictive analytics specialist Health Outcomes Sciences

    ACC.21 switches to a virtual-only meeting

    Urgent action needed to address growing burden of heart failure

    CRT 2021: Recre8 sub-analysis points to higher rate of clinically relevant bleeding in HBR patients during DAPT

    Study shows AI can “extend the reach” of echocardiographic assessment

    OpSens gains CE mark for OptoWire III

    MRI study of COVID-19 patients with raised troponin levels reveals high rate of heart damage

    Teleflex completes enrolment in CTO-PCI IDE study

    Shockwave IVL receives US FDA pre-market approval for severely calcified coronary artery disease

    Ticagrelor monotherapy associated with a lower bleeding risk than standard DAPT after PCI

    Substantial reduction in tricuspid regurgitation reported in 30-day outcomes of CLASP TR study of Pascal device

    Off-pump CABG “an effective option” for patients with reduced ejection fraction

    Global heart failure cases soar since 1990

    New recommendations issued on antithrombotic treatment of AF patients undergoing PCI

    Meta-analysis points to “inverse” relationship between TAVI centre volume and outcomes

    First patient enrolled in SUCCESS PTA post-market study of Selution drug-eluting balloon

    iVascular announces availability of Angiolite DES for longer lesions

    Philips completes acquisition of cardiac diagnostics specialist BioTelemetry

    Puzzle Medical receives breakthrough designation for its transcatheter pump device

    First European patient treated with Diamondback 360 coronary orbital atherectomy system

    COVID-19 patients at greater risk of death after cardiac arrest

    Rate of target vessel failure “significantly lower” after IVUS-guided PCI

    Study documents “surprisingly benign” impact of COVID-19 among cardiac surgery patients

    everolimus

    Cardiovascular Systems and Chansu Vascular Technologies partner to develop new everolimus DCBs

    Comparative study reports favourable outcomes for VasoStat haemostasis device

    STS 2021: Risk of burnout “a growing concern” in cardiothoracic surgery

    STS 2021: Sean C Grondin elected STS president

    STS 2021: Five-year COMMENCE results favour Resilia tissue aortic valve

    STS 2021: Study identifies significant gender disparities in CABG

    STS 2021: Cardiothoracic surgery suffers due to COVID-19

    STS 2021: Study of Impella 5.5 reports 79% survival rate at explant

    Analysis of ADAPT-DES registry grades risk of stent thrombosis after PCI

    Ancora Heart enrols first patient in the CORCINCH-HF study

    EU patients enrolled in REVERSE-IT trial of bentracimab for reversal of antiplatelet effects of ticagrelor

    SIS Medical announces publication of results of ISAR-CALC study for its high-pressure balloon catheter

    Scoring systems may overstate risk of minimally invasive aortic valve procedures

    NHS England mandates adoption of HeartFlow analysis for coronary heart disease

    Tria

    Study backs biopolymer used in Foldax’s Tria valve

    Alleviant Medical receives FDA breakthrough designation for transcatheter technology

    Aktiia’s wrist-mounted blood pressure monitor gains CE mark

    Social determinants key in assessing coronary heart disease risk

    Patients “fearful” of seeking cardiac care during pandemic

    “A huge loss to the cardiology community”: Tributes paid to Prof David Foley

    Diamondback 360 atherectomy system gains CE mark

    Elixir Medical announces treatment of first patient in BIOADAPTOR trial

    Abbott receives expanded Medicare reimbursement for MitraClip

    Occlutech’s atrial flow regulator receives breakthrough designation for heart failure patients

    Results from EXTRACT-PE trial of Penumbra’s Indigo aspiration system published

    “This is the tip of the iceberg” warns BHF as cardiothoracic surgeries cancelled

    iVascular announces 6mm maximum overexpansion capacity for Angiolite DES

    Complete revascularisation achieved in one quarter of patients with acute MI complicated by cardiogenic shock

    First remote robotic-assisted PCI completed in Europe using R-One platform

    The Foundry announces first-in-human procedure in study of Half Moon TMVR device

    Inari Medical’s FlowTriever receives FDA clearance for treatment of right atrial clot in transit

    Medtronic gets Health Canada approval for use of Evolut in low-risk aortic stenosis patients

    ACC.21 to offer remote COVID-19 screening

    CathWorks raises funds to support commercialisation of FFRangio system

    “Change in culture” needed to increase RCTs in cardiothoracic surgery

    <